angiotensinconvert
enzym
ace
major
target
treatment
cardiovascular
diseas
cvd
addit
ace
homolog
ace
promot
degrad
angiotensin
ii
angii
ang
recogn
recent
potenti
therapeut
target
manag
cvd
articl
review
differ
metabol
pathway
ace
receptor
angiang
ma
receptor
regul
cardiovascular
function
potenti
new
drug
develop
therapi
cvd
addit
recent
progress
studi
angiotensin
ace
fetal
origin
cardiovascular
diseas
might
present
interest
field
perinat
medicin
prevent
medicin
briefli
summar
well
establish
reninangiotensin
system
ra
import
regul
cardiovascular
function
pivot
role
pathophysiolog
develop
variou
cardiovascular
diseas
cvd
addit
systemat
ra
mani
tissu
bodi
includ
brain
contain
local
ra
blood
volum
well
bodi
fluid
balanc
mediat
seem
import
function
role
develop
action
suggest
counteract
shortand
longterm
effect
vasoconstrict
cell
prolifer
increas
evid
support
role
regul
cellular
growth
differenti
apoptosi
regener
neuron
tissu
sever
studi
therefor
aim
ang
ii
receptor
drug
antagonist
losartan
use
basic
research
clinic
applic
treatment
cvd
besid
pharmacolog
target
ang
ii
receptor
ace
recogn
one
major
target
treatment
hypertens
cvd
clinic
basic
research
therefor
ace
inhibitor
acei
andor
specif
blocker
arb
use
effect
drug
inhibit
aceang
axi
manag
cvd
ra
far
complex
initi
anticip
howev
recent
year
sever
novel
compon
ra
discov
pro
renin
receptor
gproteincoupl
receptor
ma
add
complex
ra
one
new
aspect
potenti
drug
develop
identif
figur
new
homolog
ace
favor
degrad
ang
ii
ang
ang
bind
ma
receptor
consid
benefici
peptid
ra
cascad
cardiovascular
system
action
ma
axi
often
opposit
welldocu
aceang
axi
accordingli
sever
studi
suggest
activ
ma
axi
prevent
even
reduc
damag
observ
cvd
unlik
ubiquit
ace
origin
thought
predominantli
express
heart
kidney
testi
tissu
subsequ
studi
howev
show
much
widespread
distribut
lung
liver
small
intestin
brain
although
level
lower
kidney
seem
peripher
central
might
involv
cardiovascular
regul
addit
mani
recent
epidemiolog
studi
demonstr
fetal
origin
hypertens
cvd
abnorm
develop
ra
fetu
play
import
part
increas
risk
cvd
adult
studi
past
two
decad
shown
ra
crucial
control
fetal
cardiovascular
respons
bodi
fluid
balanc
neuroendocrin
regul
also
postnat
health
ill
alter
normal
develop
fetal
ra
environment
insult
pregnanc
might
signific
impact
utero
program
hypertens
cvd
later
life
articl
briefli
review
recent
discov
physiolog
pathophysiolog
effect
peripher
brain
ace
cardiovascular
homeostasi
acei
clinic
relev
cvd
discuss
addit
summar
new
progress
studi
fetal
ra
develop
link
ace
might
present
interest
field
perinat
medicin
prevent
medicin
structur
biochem
properti
ace
ace
zinc
metallopeptidas
convert
inact
ang
activ
ang
ii
cleav
dipeptid
histidineleucin
c
termin
ang
key
enzym
ra
product
ang
ii
ace
distribut
throughout
bodi
includ
central
nervou
system
cn
ace
exist
membranebound
solubl
form
latter
exist
blood
plasma
amniot
fluid
semin
plasma
bodi
fluid
two
distinct
isoenzym
ace
endotheli
isoenzym
somat
form
present
throughout
bodi
compos
two
highli
similar
domain
bear
function
catalyt
site
isoenzym
germin
form
found
exclus
testi
except
approxim
amino
acid
n
terminu
ident
ctermin
domain
endotheli
ace
thu
contain
singl
catalyt
site
form
ace
function
cell
surfac
ectoenzym
hydrolyz
circul
peptid
ace
kininas
ii
origin
name
abil
convert
ang
ang
ii
inactiv
bradykinin
ace
act
peptidyl
dipeptidas
remov
coohtermin
dipeptid
activ
peptid
contain
free
cooh
terminu
howev
mani
studi
demonstr
also
act
endopeptidas
substrat
substanc
p
luteinizinghormonereleas
hormon
inde
physiolog
substrat
ace
broad
includ
ang
bradykinin
substanc
p
also
hemoregulatori
peptid
nacetylserasplyspro
nacetylserasplyspro
put
bone
marrow
suppressor
hematopoiet
factor
natur
substrat
nh
termin
domain
ace
might
role
hemopoiet
cell
differenti
wherea
domain
thought
import
regul
tissu
blood
level
vasoact
hormon
ang
ii
bradykinin
ang
found
year
ago
ang
also
could
substrat
ace
identifi
propeptid
ra
plasma
tissu
nagata
et
al
agtderiv
product
previous
unrecogn
import
precursor
peptid
ra
cascad
inject
intraven
rat
ang
immedi
rais
bp
vasoconstrictor
pressor
effect
mostli
disappear
administr
acei
ang
receptor
blocker
previou
studi
suggest
direct
enzymat
convers
ang
ang
seem
mediat
serum
ace
prosser
colleagu
howev
demonstr
recent
ang
convert
ang
ii
cardiac
chymas
rat
enzym
express
tissu
mast
cell
increas
acei
therapi
inhibit
ace
activ
prove
import
treatment
hypertens
cvd
ace
endotheliumbound
carboxypeptidas
cleav
distinct
metalloproteas
locat
cell
surfac
releas
solubl
form
share
mani
biochem
properti
contrast
wideexpress
ace
howev
express
initi
describ
heart
kidney
testi
express
initi
thought
limit
mainli
endotheli
cell
arteri
arteriol
venul
heart
kidney
renal
tubular
epithelium
vascular
smooth
muscl
cell
intraren
arteri
coronari
blood
vessel
recent
studi
shown
express
also
ubiquit
brain
cardiovascularrelev
tissu
unlik
ace
function
strict
carboxypeptidas
cleav
singl
ctermin
residu
distinct
rang
substrat
rather
dipeptid
therefor
abl
cleav
decapeptid
ang
ang
octapeptid
ang
ii
ang
vitro
figur
major
role
ang
peptid
metabol
produc
ang
howev
oppos
action
ang
ii
mediat
vasodilat
antiprolifer
therefor
ang
pathway
may
counterbal
physiolog
pathophysiolog
effect
aceang
ii
pathway
seem
convers
ang
ang
via
normal
physiolog
import
except
condit
rais
ang
ii
level
eg
acei
arb
treatment
addit
ang
ang
ii
also
show
broad
substrat
specif
particip
metabol
peptid
relat
ra
neurotensin
dynorphin
ghrelin
desarg
bradykinin
bradykinin
howev
physiolog
signific
regul
peptid
unclear
despit
share
mani
biochem
properti
ace
insensit
classic
acei
homolog
ace
share
sequenc
ident
ace
metalloproteas
catalyt
region
comparison
genom
structur
indic
two
gene
similar
collectrin
anoth
homolog
express
exclus
kidney
human
collectrin
ident
noncatalyt
extracellular
transmembran
cytosol
domain
howev
unlik
ace
collectrin
lack
activ
dipeptidyl
carboxypeptidas
catalyt
domain
ace
gene
locat
chromosom
collectrin
gene
locat
close
region
x
chromosom
shown
gene
local
hypertensionrel
quantit
trait
locu
x
chromosom
increas
evid
show
crucial
role
regul
bp
cardiovascular
function
exampl
recent
studi
suggest
strong
associ
gene
polymorph
hypertens
patient
metabol
syndrom
essenti
hypertens
left
ventricular
hypertrophi
hypertroph
cardiomyopathi
coronari
heart
diseas
myocardi
infarct
effect
peripher
ace
cardiovascular
system
distribut
ace
peripherya
mention
signific
bodi
evid
demonstr
ace
wide
express
lung
also
mani
tissu
includ
renal
proxim
tubular
epithelium
vascular
adventitia
gut
macrophag
select
portion
brain
exampl
cardiac
ace
mrna
detect
easili
rat
human
heart
ace
activ
also
readili
detect
sever
method
autoradiographi
enzymat
assay
demonstr
ace
present
viabl
cardiomyocyt
cardiac
blood
vessel
endocardium
either
normal
condit
myocardi
infarct
howev
mani
report
convert
enzym
activ
blood
vessel
associ
endothelium
inde
differ
layer
vascular
wall
data
consist
wilson
et
al
rogerson
et
al
report
predomin
label
ace
endothelium
adventitia
arnal
et
al
show
high
level
express
ace
mrna
protein
media
rat
aorta
express
level
almost
high
endothelium
wherea
express
rel
low
adventitia
ham
et
al
investig
local
protein
variou
human
organ
found
present
arteri
venou
endotheli
cell
arteri
smooth
muscl
cell
organ
studi
addit
studi
requir
clarif
accumul
data
show
kidney
also
contain
local
tissu
ra
play
import
part
control
renal
function
bp
regul
ace
express
proxim
tubular
brush
border
kidney
express
also
demonstr
heart
vasculatur
local
endotheli
smooth
muscl
cell
intramyocardi
vessel
cardiac
myocyt
also
found
thorac
aorta
carotid
arteri
vein
kidney
predominantli
express
proxim
tubular
brush
border
coloc
ace
also
found
endotheli
smooth
muscl
cell
renal
vessel
glomerular
viscer
pariet
epitheli
cell
studi
target
homolog
recombin
mous
embryon
stem
cell
provid
surpris
seri
insight
action
function
import
ra
null
mice
null
express
ace
mice
shown
profound
reduct
bp
inabl
concentr
urin
maldevelop
kidney
contrast
tissu
null
mice
produc
approxim
normal
ace
enzymat
activ
complet
lack
tissu
ace
also
low
bp
reduc
bp
key
featur
ace
defici
ace
mice
investig
fine
control
bodi
physiolog
ra
cole
et
al
develop
novel
promot
swap
approach
gener
select
tissu
knockout
ace
express
approach
liver
ace
mous
model
produc
select
express
ace
liver
lack
ace
within
vasculatur
surprisingli
studi
mice
show
endotheli
express
ace
requir
bp
control
normal
renal
function
demonstr
acedefici
mice
neither
defect
heart
develop
prone
heart
diseas
acedefici
mice
heart
histolog
normal
defect
heart
function
detect
nonetheless
ace
play
import
part
vascular
remodel
vascular
injuri
restenosi
hypertens
atherosclerosi
peripher
cardiovascular
functionincreas
evid
indic
crucial
role
cardiovascular
homeostasi
alter
express
associ
major
cardiac
vascular
pathophysiolog
shown
patient
hypertens
show
mark
ace
upregul
downregul
heart
kidney
suggest
disrupt
balanc
ace
result
abnorm
bp
control
thu
might
protect
increas
bp
defici
might
lead
hypertens
crackow
et
al
first
test
gene
underli
bp
locu
x
chromosom
report
low
level
kidney
three
hypertens
rat
stain
saltsensit
sabra
hypertens
rat
mrna
protein
express
lower
saltresist
sabra
normotens
rat
spontan
hypertens
rat
shr
spontan
hypertens
strokepron
rat
kidney
express
also
decreas
compar
wistarkyoto
control
rat
recent
find
new
congen
hypertens
rat
strain
lewtg
deriv
transgen
show
treatment
acei
lisinopril
arb
losartan
induc
increas
cardiac
renal
express
andor
activ
decreas
bp
taken
togeth
find
indic
key
element
regul
bp
nonetheless
signific
hypertens
need
studi
previou
studi
shown
delet
result
signific
alter
cardiac
vascular
function
observ
mainli
knockout
anim
exampl
crackow
et
al
first
demonstr
null
mice
exhibit
sever
reduct
cardiac
contractil
decreas
aortic
ventricular
pressur
interestingli
anim
show
chang
bp
although
plasma
tissu
level
ang
ii
increas
significantli
cardiac
contractil
dysfunct
complet
revers
concomit
delet
ace
gene
knockout
mice
suggest
cardiac
function
modul
balanc
ace
increas
local
cardiac
ang
ii
involv
abnorm
contrast
gurley
et
al
demonstr
null
mice
lack
cardiac
structur
function
chang
exhibit
small
elev
baselin
bp
enhanc
suscept
ang
iiinduc
hypertens
recent
studi
shown
chang
background
variabl
chang
mix
anim
anoth
studi
yamamoto
et
al
also
fail
identifi
cardiac
abnorm
knockout
mice
howev
demonstr
reduc
cardiac
contractil
transvers
aortic
constrict
model
pressur
overload
transvers
aortic
constrict
knockout
mice
associ
mark
increas
cardiac
ang
ii
level
increas
fibrosi
left
ventricular
dilat
myofibrillar
disarray
compar
wildtyp
mice
subject
procedur
might
influenc
electr
pathway
heart
howev
inde
donoghu
colleagu
show
spontan
lethal
episod
ventricular
tachycardia
fibril
develop
transgen
mice
level
upregul
correl
sever
conduct
disturb
support
previou
studi
demonstr
high
concentr
ang
heart
induc
cardiac
arrhythmia
find
suggest
import
role
counteract
effect
accumul
ang
ii
studi
demonstr
import
role
cardiac
function
burrel
et
al
show
increas
myocardi
infarct
suggest
enzym
play
part
neg
modul
ra
metabol
ang
peptid
myocardi
injuri
cardiac
hypertrophi
fibrosi
hypertens
found
associ
increas
cardiac
gene
express
activ
rat
ang
form
activ
also
observ
patient
either
idiopath
dilat
cardiomyopathi
primari
pulmonari
hypertens
inhibit
inhibitor
recent
studi
myocardi
infarct
anim
shown
use
ang
ii
format
inhibitor
ie
acei
arb
result
increas
transcript
translat
observ
impli
upregul
compensatori
respons
inhibit
ang
ii
demonstr
peripher
exert
pivot
role
cardiovascular
function
indic
great
potenti
drug
develop
target
brain
ace
cardiovascular
functionin
brain
ace
mrna
express
choroid
plexu
caudat
putamen
cerebellum
brain
stem
hippocampu
rat
local
ace
protein
cn
verifi
quantit
autoradiographi
high
level
choroid
plexu
blood
vessel
subforn
organ
sfo
organum
vasculosum
lamina
terminali
lower
level
thalamu
hypothalamu
basal
ganglia
posterior
pituitari
gland
larg
bodi
evid
show
hyperact
brain
ra
play
crucial
part
develop
mainten
hypertens
although
precis
mechan
ang
ii
trigger
hypertens
clear
seem
involv
increas
sympathet
vasomotor
tone
alter
cardiac
baroreflex
function
ang
ii
act
brain
induc
increas
bp
promot
vasoconstrict
renal
sodium
water
reabsorpt
increas
cardiac
output
sympathet
tone
arginin
vasopressin
avp
releas
stimul
sensat
thirst
cn
shr
upregul
brain
ra
compon
agt
ang
ii
ace
preced
sustain
develop
hypertens
brain
cardiovascular
functionmani
recent
studi
shown
widespread
throughout
brain
addit
studi
perform
brain
cell
cultur
demonstr
express
predominantli
glial
cell
initi
studi
evid
role
cn
emerg
rapidli
exampl
use
select
antibodi
doobay
et
al
found
present
nuclei
like
cardiorespiratori
neuron
brainstem
involv
central
regul
cardiovascular
function
also
noncardiovascular
area
motor
cortex
raph
addit
lin
et
al
show
presenc
mrna
protein
mous
brainstem
find
suggest
broad
effect
cn
addit
regul
cardiovascular
function
well
establish
ma
axi
new
avenu
action
ra
emerg
evid
clearli
support
principl
ma
axi
physiolog
relev
arm
ra
counterbalanc
action
aceang
pathway
metabol
ang
ii
vasodilatori
peptid
ang
therefor
extent
physiolog
role
central
ang
indic
role
brain
ang
act
bind
receptor
ma
demonstr
highli
express
brain
larg
bodi
evid
role
ang
cn
ang
shown
pleiotrop
bioactiv
compon
ra
exert
effect
ident
differ
opposit
display
ang
ii
exampl
mimic
ang
ii
stimul
avp
prostaglandin
releas
well
peripher
norepinephrin
outflow
contrast
ang
caus
natriuresi
diuresi
vasodilat
well
inhibit
angiogenesi
cellular
growth
mani
case
peptid
act
endogen
antagonist
ang
ii
ang
suggest
antihypertens
effect
well
counterbalanc
pressor
prolif
action
ang
ii
effect
oppos
ang
ii
enhanc
rat
model
hypertens
intracerebroventricular
infus
ang
induc
signific
increas
baroreceptor
control
heart
rate
sensit
reflex
bradycardia
central
ang
exert
antihypertens
effect
mani
way
gironacci
et
al
demonstr
central
ang
decreas
sympathet
nervou
system
activ
inhibit
norepinephrin
releas
hypothalamu
shr
act
bradykinin
nitric
oxidemedi
mechan
stimul
cgmpprotein
kinas
g
signal
pathway
might
also
particip
potenti
bradykinin
releas
kinin
receptor
express
accordingli
wide
accept
play
pivot
part
central
control
cardiovascular
homeostasi
diz
et
al
report
recent
activ
well
ace
neprilysin
activ
present
plasma
membran
fraction
dorsomedi
medulla
spraguedawley
rat
inject
ang
antagonist
dala
ang
nucleu
tractu
solitarii
nt
reduc
baroreceptor
reflex
sensit
control
heart
rate
wherea
inject
antagonist
candesartan
increas
baroreceptor
reflex
sensit
reflex
bradycardia
assess
consist
inject
potent
select
inhibitor
current
avail
nt
reduc
baroreceptor
reflex
sensit
find
support
concept
within
nt
local
synthesi
ang
ang
ii
requir
normal
sensit
baroreflex
control
heart
rate
respons
increas
arteri
pressur
xia
et
al
report
activ
central
reduc
activ
hypertens
mice
therebi
impair
baroreflex
function
promot
hypertens
overexpress
brain
reduc
hypertens
improv
arteri
baroreflex
autonom
function
support
idea
brain
play
crucial
part
central
regul
bp
develop
hypertens
moreov
overexpress
sfo
also
impair
ang
iimedi
pressor
dipsogen
respons
mediat
least
part
inhibit
express
experiment
result
offer
new
target
treatment
hypertens
cvd
studi
brain
role
cardiovascular
system
still
limit
howev
although
import
inform
come
recent
year
doobay
cowork
recent
examin
immunostain
transgen
mous
brain
section
neuronspecif
enolaseat
overexpress
receptor
r
overexpress
agt
renin
control
nontransgen
litterm
mice
studi
show
stain
wide
distribut
throughout
brain
local
cytoplasm
neuron
cell
sfo
increas
significantli
transgen
mice
wherea
brainstem
mrna
protein
express
invers
chang
compar
transgen
nontransgen
mice
support
subsequ
studi
lin
et
al
demonstr
reduct
mrna
associ
reduct
mrna
brainstem
use
gene
silenc
approach
find
suggest
level
tightli
regul
compon
ra
support
notion
act
compensatori
mechan
limit
brain
ra
hyperact
moreov
express
brain
area
involv
control
cardiovascular
function
suggest
crucial
role
central
regul
bp
diseas
involv
autonom
nervou
system
hypertens
addit
feng
et
al
show
recent
overexpress
sfo
impair
ang
iimedi
pressor
drink
respons
least
inhibit
express
indic
effect
downregul
region
studi
need
address
detail
phenomenon
observ
aceang
axi
long
thought
main
path
ra
control
cardiovascular
function
therefor
specif
acei
arb
major
therapeut
strategi
treatment
hypertens
cvd
mani
potent
acei
synthes
subsequ
evalu
clinic
trial
well
known
ace
key
enzym
ra
convert
ang
ang
ii
degrad
bradykinin
inact
peptid
mani
cvd
level
ace
increas
result
increas
circul
tissu
level
ang
ii
decreas
level
bradykinin
imbal
ang
ii
bradykinin
induc
harm
effect
myocardi
vascular
function
structur
includ
vasoconstrict
salt
water
retent
ventricular
hypertrophi
sympathet
nervou
system
overstimul
vascular
smooth
muscl
cell
prolifer
acei
block
convers
ang
ang
ii
inhibit
breakdown
bradykinin
recov
balanc
ang
ii
bradykinin
evid
clinic
trial
demonstr
ace
inhibit
impact
almost
class
cardiovascular
drug
reduc
risk
myocardi
infarct
stroke
diabet
mellitu
renal
impair
shown
benefit
patient
hypertens
heart
failur
left
ventricular
dysfunct
postmyocardi
infarct
nephropathi
peripher
vascular
diseas
diabet
stroke
transient
ischem
attack
novel
function
role
ace
involv
outsidein
signal
identifi
fleme
cowork
investig
show
bind
acei
ace
led
activ
signal
event
like
affect
express
sever
protein
character
novel
signal
pathway
via
ace
also
suggest
benefici
effect
acei
attribut
activ
distinct
ace
signal
cascad
rather
chang
ang
ii
bradykinin
level
addit
ace
inhibit
ra
also
inhibit
arb
acei
arb
signific
protect
effect
myocardi
vascular
function
addit
antihypertens
effect
sever
studi
note
mark
increas
cardiac
express
respons
ra
blockad
acei
arb
figur
cardioprotect
ra
blockad
caus
reduc
ang
iimedi
effect
also
local
increas
ang
benefici
effect
heart
bind
put
receptor
ma
howev
sever
clinic
investig
found
class
drug
limit
exampl
patient
increas
plasma
ang
ii
concentr
observ
acei
therapi
partli
product
ang
ii
via
nonac
pathway
moreov
elev
aldosteron
concentr
also
occur
signific
proport
patient
acei
therapi
contrast
arb
block
deleteri
effect
ang
ii
wherea
benefici
effect
kinin
might
diminish
arb
therapi
result
activ
result
potenti
benefici
antiinflammatori
antithrombot
antiprolif
effect
combin
therapi
acei
plu
arb
offer
potenti
effect
bp
control
decreas
aldosteron
product
enhanc
kinin
activ
thu
focu
recent
clinic
trial
current
investig
addit
also
possibl
consid
singl
drug
contain
acei
arb
variou
concentr
two
inhibitor
sever
year
ace
thought
major
regulatori
enzym
ra
discoveri
gain
recognit
import
regul
cardiovascular
function
emerg
evid
clearli
support
concept
ma
axi
physiolog
cardioprotect
pathway
ra
counterbalanc
action
aceang
pathway
express
activ
alter
sever
cvd
includ
hypertens
renal
damag
heart
failur
vascular
remodel
therefor
ma
pathway
offer
opportun
develop
new
refin
therapeut
strategi
cvd
embark
therapeut
aspect
howev
investig
need
elucid
detail
exact
mechan
regul
cardiovascular
function
inhibitor
new
select
drug
activ
target
explor
oppos
vasoact
prolif
action
ang
ii
show
benefici
effect
cardiovascular
system
upregul
express
activ
desir
characterist
treatment
cvd
increas
level
stimul
express
exogen
applic
recombin
might
benefici
effect
sever
diseas
condit
scope
futur
studi
actual
recent
data
sever
group
shown
gene
therapi
provid
benefici
effect
cardiovascular
function
research
overexpress
heart
adult
anim
use
gene
transfer
techniqu
found
gene
deliveri
abl
protect
heart
myocardi
injuri
induc
ang
ii
infus
ischemia
damag
elicit
high
bp
shr
addit
recent
studi
shown
administr
activ
might
valid
strategi
antihypertens
therapi
prada
et
al
demonstr
xanthenon
compound
enhanc
activ
caus
consider
reduct
bp
strike
revers
cardiac
renal
fibrosi
hypertens
shr
model
present
first
time
structurebas
drug
discoveri
approach
enabl
develop
enzym
activ
clinic
ramif
studi
signific
cvd
diseas
associ
hypertens
obes
diabet
compar
extens
studi
ra
adult
investig
relat
ra
fetu
substanti
fewer
sinc
concept
fetal
origin
adult
health
diseas
introduc
howev
develop
ra
normal
abnorm
pattern
birth
attract
great
attent
increas
evid
suggest
overactiv
ra
includ
increas
ace
activ
contribut
significantli
fetal
program
hypertens
adult
ace
immunoreact
demonstr
human
fetal
brain
ace
mrna
protein
detect
choroid
plexu
brain
region
fetal
rat
rabbit
rat
fetal
brain
day
gestat
ace
detect
choroid
plexu
sfo
posterior
pituitari
extrapyramid
structur
anterior
pituitari
birth
ace
identifi
caudateputamen
contrast
express
brain
absent
embryon
day
prompt
increas
express
follow
physiolog
question
rais
immedi
discoveri
ace
fetal
brain
ie
whether
brain
ace
fetu
function
develop
although
ace
express
develop
fetu
birth
function
develop
enzym
less
understood
recent
studi
investig
function
develop
brain
ace
relat
cardiovascular
regul
utero
chronic
prepar
nearterm
ovin
fetu
intracerebroventricular
inject
ang
utero
surviv
surgeri
exert
ovin
fetus
intracrani
cannula
place
fetal
later
ventricl
gestat
recoveri
day
fetal
sheep
test
found
intracerebroventricular
inject
ang
substrat
ace
induc
ang
iilik
physiolog
action
includ
increas
fetal
bp
plasma
avp
concentr
well
cfo
express
put
cardiovascular
nuclei
paraventricular
nuclei
captopril
inhibitor
ace
suppress
ang
iinduc
respons
significantli
result
indic
function
develop
central
endogen
ace
establish
least
last
third
gestat
endogen
brain
rasstimul
pressor
respons
avp
releas
act
site
consist
cardiovascular
network
hypothalamu
shi
et
al
unpublish
data
last
third
gestat
crucial
function
develop
might
serv
vulner
window
face
environment
insult
lead
diseas
program
novel
inform
gain
fetal
sheep
contribut
understand
normal
neurophysiolog
develop
fetal
brain
also
knowledg
rasmedi
hypertens
develop
fetal
origin
increas
evid
support
concept
advers
event
perinat
environ
predispos
individu
diseas
later
life
ace
coexpress
mani
tissu
alter
express
activ
might
particip
fetal
program
hypertens
exampl
anim
model
lowprotein
diet
pregnanc
elev
bp
adult
offspr
associ
increas
pulmonari
plasma
ace
activ
acei
prevent
increas
bp
addit
hypertens
lamb
expos
low
protein
utero
associ
enhanc
renal
ace
protein
express
although
glucocorticoid
exposur
acut
increas
ace
express
vascular
smooth
muscl
chronic
upregul
ra
compon
might
also
occur
result
inappropri
exposur
glucocorticoid
utero
recent
shaltout
et
al
investig
effect
antenat
betamethason
given
sheep
dose
gestat
time
point
similar
therapi
women
risk
preterm
deliveri
receiv
found
antenat
betamethason
treatment
increas
mean
arteri
pressur
versu
mmhg
p
adult
offspr
increas
bp
block
antagonist
candesartan
suggest
higher
vasoconstrictor
tone
betamethasonetr
anim
control
anim
evalu
sever
key
enzym
crucial
maintain
balanc
ang
ii
ang
show
betamethason
treatment
associ
higher
serum
ace
activ
lower
serum
activ
support
shift
toward
greater
synthesi
ace
reduc
metabol
ang
ii
well
reduc
format
ang
alter
ratio
peptid
would
favor
elev
bp
antenat
betamethason
treatment
also
associ
reduc
activ
isol
proxim
tubul
urin
reduct
activ
compart
suggest
reduc
express
enzym
rather
increas
shed
enzym
tubular
fluid
moreov
immunoblot
proxim
tubul
reveal
lower
protein
level
consist
lower
activ
tubul
ace
neprilysin
activ
proxim
tubul
alter
antenat
betamethason
treatment
taken
togeth
data
indic
antenat
steroid
treatment
result
chronic
alter
ace
circulatori
tubular
compart
might
contribut
increas
bp
fetal
program
hypertens
ra
essenti
role
patholog
develop
blood
vessel
growth
cooper
colleagu
found
infant
born
women
took
acei
first
trimest
pregnanc
excess
major
congenit
malform
compar
unexpos
women
support
notion
inhibit
blood
vessel
format
might
account
congenit
abnorm
owe
exposur
acei
first
trimest
howev
mice
lack
ace
show
evid
congenit
abnorm
seen
human
fetus
expos
acei
differ
current
fulli
understood
develop
brain
heart
fetu
major
site
format
blood
vessel
pattern
recent
report
malform
result
exposur
acei
first
trimest
consist
impair
vasculogenesi
earli
angiogenesi
howev
precis
role
differ
constitu
system
remain
poorli
understood
anticip
prenat
medicin
prevent
diseas
fetal
origin
attract
attent
given
sever
adult
diseas
develop
origin
prenat
stage
recent
progress
made
show
ra
play
import
part
program
diseas
initi
fetal
period
therefor
futur
direct
prevent
rasmedi
diseas
fetal
origin
might
focu
ace
inhibitor
prenat
postnat
stage
differ
metabol
avenu
lead
ang
ang
pathway
via
ace
ang
ma
pathway
via
demonstr
past
decad
import
point
differ
two
pathway
lie
opposit
effect
could
either
harm
benefit
cardiovascular
regul
induc
prevent
certain
cvd
accumul
evid
effect
ace
basic
clinic
studi
open
new
opportun
develop
new
drug
base
differ
metabol
effect
ace
furthermor
prevent
certain
type
hypertens
reduc
risk
cvd
fetal
origin
drug
target
ace
could
consid
prevent
tool
prenat
medicin
futur
angiotensinogen
transform
ang
renin
subsequ
convert
ace
ang
ii
ang
also
cleav
ang
ang
convert
ace
ang
ang
ii
act
lead
physiolog
pathophysiolog
activ
act
ma
receptor
ang
might
attenu
action
aceang
axi
solid
dash
line
indic
posit
neg
effect
respect
ace
angiotensinconvert
enzym
angiotensin
ii
type
receptor
ma
ang
receptor
acei
ace
inhibitor
arb
blocker
